Sygnature Discovery acquires Peak Proteins
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Through the association, Aster Volunteers would support 50 children from underprivileged families undergo liver transplants at Aster CMI and Aster RV Hospitals in Bangalore, and Aster Medcity and Aster MIMS Hospital Calicut in Kerala, India
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
Subscribe To Our Newsletter & Stay Updated